X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4232) 4232
Publication (663) 663
Book Chapter (26) 26
Book Review (26) 26
Dissertation (18) 18
Conference Proceeding (8) 8
Government Document (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2701) 2701
index medicus (2500) 2500
jak2 (1906) 1906
hematology (1602) 1602
mutation (1392) 1392
polycythemia-vera (1379) 1379
janus kinase 2 - genetics (1346) 1346
tyrosine kinase jak2 (1152) 1152
oncology (1116) 1116
animals (1104) 1104
essential thrombocythemia (1090) 1090
female (1071) 1071
male (1071) 1071
myeloproliferative disorders (808) 808
middle aged (759) 759
myelofibrosis (698) 698
myeloproliferative neoplasms (681) 681
janus kinase 2 (677) 677
aged (664) 664
janus kinase 2 - metabolism (664) 664
mice (660) 660
adult (637) 637
myeloproliferative disorders - genetics (585) 585
signal transduction (570) 570
phosphorylation (489) 489
genetic aspects (487) 487
biochemistry & molecular biology (470) 470
cell biology (440) 440
expression (439) 439
activation (437) 437
leukemia (408) 408
aged, 80 and over (401) 401
janus kinase 2 - antagonists & inhibitors (400) 400
polycythemia vera (400) 400
hemic and lymphatic diseases (376) 376
research (376) 376
jak2 v617f mutation (370) 370
myeloid metaplasia (366) 366
polycythemia vera - genetics (354) 354
apoptosis (352) 352
cancer (348) 348
tumors (343) 343
analysis (342) 342
thrombocythemia, essential - genetics (338) 338
stat3 (310) 310
article (302) 302
signal transduction - drug effects (302) 302
primary myelofibrosis - genetics (295) 295
primary myelofibrosis (294) 294
cell line, tumor (290) 290
disorders (285) 285
kinases (275) 275
activating mutation (274) 274
health aspects (270) 270
diagnosis (269) 269
prognosis (263) 263
risk factors (258) 258
stat3 transcription factor - metabolism (256) 256
care and treatment (251) 251
abridged index medicus (250) 250
proteins (244) 244
cells (243) 243
jak2 inhibitor (243) 243
thrombosis (243) 243
gene expression (233) 233
cell line (231) 231
pharmacology & pharmacy (231) 231
jak2 mutation (230) 230
chronic myeloproliferative disorders (229) 229
medicine & public health (217) 217
adolescent (215) 215
medicine, research & experimental (212) 212
hematology, oncology and palliative medicine (208) 208
ruxolitinib (208) 208
rats (206) 206
pathology (203) 203
protein-tyrosine kinases - metabolism (203) 203
gene mutations (202) 202
polycythemia (202) 202
jak2 v617f (200) 200
protein kinase inhibitors - pharmacology (200) 200
v617f mutation (198) 198
young adult (196) 196
cells, cultured (191) 191
mutation, missense (190) 190
cytokines (188) 188
acute myeloid-leukemia (186) 186
myeloproliferative disorders - pathology (184) 184
mutations (183) 183
jak2/stat3 (180) 180
receptor (180) 180
alleles (178) 178
amino acid substitution (177) 177
jak2v617f (177) 177
point mutation (171) 171
myeloproliferative disorders - diagnosis (169) 169
protein kinase inhibitors - therapeutic use (169) 169
disease (166) 166
immunology (166) 166
receptors, thrombopoietin - genetics (165) 165
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4176) 4176
French (23) 23
Japanese (17) 17
Korean (11) 11
German (10) 10
Chinese (9) 9
Spanish (9) 9
Hungarian (5) 5
Persian (1) 1
Polish (1) 1
Russian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 09/2012, Volume 489, Issue 7414, pp. 155 - 159
The identification of somatic activating mutations in JAK2 (refs 1-4) and in the thrombopoietin receptor gene (MPL)(5) in most patients with myeloproliferative... 
MYELOFIBROSIS | LUNG-CANCER | POLYCYTHEMIA-VERA | GEFITINIB | MYELOPROLIFERATIVE DISORDERS | TYROSINE KINASE | MULTIDISCIPLINARY SCIENCES | BCR-ABL | MUTATION | RESISTANCE | CHRONIC MYELOID-LEUKEMIA | Myeloproliferative Disorders - enzymology | Phosphorylation | Protein Biosynthesis | Humans | Protein Multimerization | STAT Transcription Factors - metabolism | TYK2 Kinase - metabolism | Janus Kinase 1 - deficiency | TYK2 Kinase - deficiency | Myeloproliferative Disorders - pathology | Janus Kinase 1 - biosynthesis | Gene Knockdown Techniques | Janus Kinase 2 - deficiency | Janus Kinase 1 - metabolism | Granulocytes - drug effects | RNA Interference | Janus Kinase 1 - genetics | Janus Kinase 2 - metabolism | Myeloproliferative Disorders - metabolism | Granulocytes - metabolism | Janus Kinase 2 - antagonists & inhibitors | Disease Models, Animal | Cell Line | Janus Kinase 2 - genetics | Myeloproliferative Disorders - drug therapy | Enzyme Activation - drug effects | TYK2 Kinase - biosynthesis | Granulocytes - enzymology | Animals | Signal Transduction - drug effects | HSP90 Heat-Shock Proteins - antagonists & inhibitors | HSP90 Heat-Shock Proteins - metabolism | Mice | TYK2 Kinase - genetics | Drug Resistance, Neoplasm - drug effects | Enzyme inhibitors | Gene mutations | Cancer cells | Dosage and administration | Genetic aspects | Cellular signal transduction | Identification and classification | Physiological aspects | Care and treatment | Research | Myeloproliferative disorders | Cancer | tyrosine kinase inhibitors | persistence | MPN | JAK2 | resistance
Journal Article
Cellular Signalling, ISSN 0898-6568, 11/2012, Volume 24, Issue 11, pp. 2024 - 2034
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 01/2000, Volume 275, Issue 3, pp. 2103 - 2114
Journal Article
Journal Article
Blood, ISSN 0006-4971, 06/2010, Volume 115, Issue 25, pp. 5232 - 5240
Journal Article
Journal Article
Blood, ISSN 0006-4971, 04/2010, Volume 115, Issue 15, pp. 3109 - 3117
Journal Article
Blood, ISSN 0006-4971, 06/2017, Volume 129, Issue 25, pp. 3352 - 3361
Journal Article